Investor Relations Event
SK Biopharmaceuticals will hold a conference call on November 5 to present its preliminary Q3 2026 business results.
SK biopharmaceuticals Co., Ltd. Disclosures
326030 · KOSPI · Based on DART filings
Disclosures
1 total · 20 per page
Catch the next disclosure fast
Get app alerts for new disclosures from SK biopharmaceuticals Co., Ltd..